
OraSure® HIV-1 Oral Specimen Collection Device enables the collection of an oral fluid sample for use with a lab-based screening test that is used for detecting the HIV-1 virus.
Oral fluid testing provides samples that are easier to deal with than blood collections. With oral testing, insurance companies can identify HIV-1 status, providing assessment to the behavior and health status of applicants. The benefits that insurance companies see with oral fluid testing include: faster test results, less underwriting time, significant cost savings, reduction of "not takens" and an applicant- and agent-friendly experience.
Please see package insert for complete instructions.
Place the pad between the cheek and gum for 2-5 minutes.
Snap off the wand. Replace the cap and send to the lab via regular mail with the completed Laboratory Informed Consent Form.
The lab processes the sample and runs a screening enzyme immunoassay (EIA) test. Results presented in one day after sample is received by lab.
The following are frequently asked questions about OraSure Technologies' OraSure® HIV-1 Oral Specimen Collection Device. For additional information, please contact Customer Care.
The information provided on this website is intended only for the residents of the United States. The products discussed herein may have different labeling in different countries and may not be for sale in all other countries.
Page last updated: March 15, 2009